Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02908113 : Visual Perception in Preterm Infants
PhaseN/A
AgesMin: 23 Weeks Max: 42 Weeks
Eligibility
Inclusion Criteria:

- Newborn less than 32 weeks PMA hospitalized in the Hospital of Hautepierre,
Strasbourg, France)

- Consent obtained from both parents

- Social insurance coverage

Exclusion Criteria:

- Any known malformation

- Brain lesions discovered on brain ultrasound (Intra-Ventricular hemorrhage grade III
or IV periventricular Leukomalacia).

- Unstable clinical State

- Retinopathy Of Prematurity stage> 2 or in zone 1

- Family history of abnormal color vision.

- Abnormalities in auditory testing

- Transfer to another hospital expected before 40 week PMA
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02908113      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740